-
First-in-human studies by the 4Q2019 for new PD drug YTX-7739
Per Yumanity, YTX-7739 has been shown to inhibit many of the key aspects of a-synuclein toxicity.
Do you feel more hopeful there will be a cure for PD in your lifetime? If you could, would you participate in a trial like this?
Log in to reply.